Charles Raine is an Endocrinology/Metabolic physician affiliated with South Carolina State University. OpenAlex indexes 9 publications with 221 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1146 Waring St
Orangeburg, SC 291154767
Telephone
803-536-6339Provider last certified this registry record 29 Sept 2022.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20253 payments
- Insulet CorporationProgram year20252 payments
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
65.3%Insulin Analog23.9%Lantus Solostar22%Humalog Kwikpen U-10015%Toujeo Max Solostar13%Humalog11%Toujeo Solostar7%Humalog Kwikpen U-2006%Novolog5%Lyumjev4%Lyumjev Kwikpen U-1004%Fiasp Flextouch4%Basaglar Kwikpen U-1003%Lyumjev Kwikpen U-2003%Novolog Flexpen2%Part D<11 patientsGLP-1 receptor agonist13.4%Trulicity36%Mounjaro29%Ozempic21%Rybelsus14%Part D<11 patients+ 8 more classes in this area
Cardiovascular
25.5%Statin9.4%Rosuvastatin Calcium42%Atorvastatin Calcium41%Pravastatin Sodium11%Simvastatin5%Part D<11 patientsAngiotensin receptor blocker (ARB)4.8%Losartan-Hydrochlorothiazide38%Losartan Potassium26%Valsartan-Hydrochlorothiazide21%Telmisartan-Hydrochlorothiazid15%Part D<11 patients+ 6 more classes in this area
Hormonal (systemic)
7.1%l-Thyroxine5.5%Levothyroxine Sodium57%Synthroid43%Part D≥15 patientsThyroid Hormone Synthesis Inhibitor1.6%Methimazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicted Blood Glucose from Insulin Administration Based on Values from Miscoded Glucose Meters
Journal of Diabetes Science and Technology
2008 - Significant Insulin Dose Errors May Occur if Blood Glucose Results are Obtained from Miscoded Meters
Journal of Diabetes Science and Technology
2007 - What Will it Take to Get CGM Reimbursed? Examining Compelling Factors
Journal of Diabetes Science and Technology
2007
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”